ROIC společnosti Beam Therapeutics
Jaká je hodnota metriky ROIC společnosti Beam Therapeutics?
Hodnota metriky ROIC společnosti Beam Therapeutics Inc. je -9.36%
Jaká je definice metriky ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Beam Therapeutics
Čemu se věnuje společnost Beam Therapeutics?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Firmy s metrikou roic podobnou společnosti Beam Therapeutics
- Hodnota metriky ROIC společnosti CryoPort Inc je -9.40%
- Hodnota metriky ROIC společnosti Pacific Drilling SA je -9.39%
- Hodnota metriky ROIC společnosti FuelCell je -9.39%
- Hodnota metriky ROIC společnosti MBIA je -9.39%
- Hodnota metriky ROIC společnosti BlackRock Utility Infrastructure & Power Opportunities Trust je -9.38%
- Hodnota metriky ROIC společnosti Childrens Place Inc je -9.37%
- Hodnota metriky ROIC společnosti Beam Therapeutics je -9.36%
- Hodnota metriky ROIC společnosti iQIYI je -9.35%
- Hodnota metriky ROIC společnosti The Original BARK je -9.34%
- Hodnota metriky ROIC společnosti Arcotech je -9.34%
- Hodnota metriky ROIC společnosti AwoX SA je -9.33%
- Hodnota metriky ROIC společnosti Arrow Greentech je -9.32%
- Hodnota metriky ROIC společnosti Illumina Inc je -9.30%